Cell Isolation Market

Market Snapshot

Forecast Years for Cell Isolation Market:	2022 - 2028
Historical Years for Cell Isolation Market:	2016 - 2021
Revenue 2021 for Cell Isolation Market:	USD 7.90 Billion
Revenue 2028 for Cell Isolation:	USD 15.10 Billion
Revenue CAGR (2022 - 2028) for Cell Isolation Market :	18.1%
Fastest Growing Region (2022 - 2028) for Cell Isolation Market:	Asia Pacific
Largest Region (2021) for Cell Isolation Market:	North America

Cell Isolation Market: By Use Type, Type, and Region

Market Synopsis:

Global Cell Isolation market is valued at USD 7.90 Billion in 2021 and is projected to attain a value of USD 15.10 Billion by 2028 at a CAGR of 18.1% during the forecast period, 2022–2028. Biologics design and development, therapeutic protein manufacturing, in-vitro diagnostics, and other research applications all benefit from Cell Isolation. The increased frequency of chronic and infectious diseases such as cancer and COVID-19, as well as ongoing government measures to boost the biotechnology industry, are the primary drivers of market expansion.

Most businesses have been working on the development of cell-based therapeutics for COVID-19 treatment, the impact of the COVID-19 pandemic on the Cell Isolation market is projected to be enormous. Because most pharmaceutical, biotechnology, and research organisations have been concentrating on the development of cell therapy-based treatment against COVID-19, the impact of COVID-19 is likely to have a beneficial impact on the studied market.

Rising Government Investments in Cell-Based Research

The demand for novel and better medicines for diseases like cancer and cardiovascular disease has led in an increase in general research effort, as well as financing for cell-based research. The Stem Cell Therapies Mission, a 10-year road map for stem cell research in Australia, was released by the Australian government in November 2019. Under the Medical Research Future Fund (MRFF), the project would grant USD 102 million (AU$150 million) to encourage stem cell research in order to develop novel medicines. The National Institutes of Health (NIH) has greatly boosted funding for the development of cell treatments in the United States over the years. The good financing situation is boosting demand for Cell Isolation research equipment, media, reagents, and accessories.

Dearth of Skilled Professionals

Despite technological advancements and product development over the last decade, the market has been hampered by a shortage of skilled workers who can operate sophisticated instruments like flow cytometers and multi-mode readers. Flow cytometers and spectrophotometers, which are technologically modern and very complicated, produce a wide range of data outputs that require skill to analyse and review. There remains, nevertheless, a global demand-supply gap for trained people.

Market Segmentation:

Global Cell Isolation market is segmented on the basis of Product into Consumables and Instruments. Based on type into Human and Animal. By End-Use into Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks and Biotechnology and Biopharmaceutical Companies.Based on region, the Cell Isolation market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America to Continue Dominating the Cell Isolation Market

In 2021, North America dominated the Cell Isolation market over the forecast period. The market is expected to rise due to the existence of a high number of centres and institutes working in stem cell treatment research and development accounts for the region's large share. Five of the eight top colleges in the world are headquartered in the United States, including Stanford University's Institute for Stem Cell Biology and Regenerative Medicine, Harvard University's Harvard Stem Cell Institute, and Yale University's Yale Stem Cell Center.

Key Players:

Key players operating in the Cell Isolation market are: Becton Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc (US) are the major companies operating in Cell Isolation Market.

The Cell Isolation market is segmented as follows:

Parameter	Details
Segments Covered	Product (Consumables, Instruments) Type (Human, Animal) End User (Biotechnology & Biopharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research Laboratories and Institutes, Other End Users) Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered	North America - (U.S., Canada, Mexico) Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe) Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific) Latin America - (Brazil, Argentina, Rest Of Latin America) Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered	Becton Dickinson and Company (US) GE Healthcare (US) Merck KgaA (Germany) Thermo Fisher Scientific (US) Bio-Rad Laboratories Inc (US) are the major companies operating in Cell Isolation Market.
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

The Cell Isolation market scope can be tabulated as below: